Slowing of Disability Progression Based on 6-Month Confirmed EDSS in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Treated with Cladribine Tablets in the CLARITY Study: A Post-Hoc Subgroup Analysis (P3.058)
Year: 2016
Type: article
Source: Neurology
Authors: Stuart Cook, Kottil Rammohan, Peter Rieckmann, Per Soelberg-Sørensenn, Patrick Vermersch, Christine Hicking, Fernando Dangond, Gavin Giovannoni
Institutions: Rutgers New Jersey Medical School, Ohio State University Hospital, Copenhagen University Hospital, Danish Multiple Sclerosis Center, Hôpital Roger Salengro, Université Lille Nord de France, Merck KGaA, Darmstadt (Germany), EMD Serono, Inc. (United States), Queen Mary University of London, Blizard Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2511124978